SARCOMA

Latest News

FDA Grants ODD to 3 Ingredients of INT230-6 for Soft Tissue Sarcoma
FDA Grants ODD to 3 Ingredients of INT230-6 for Soft Tissue Sarcoma

September 7th 2023

INT230-6 is an investigational product candidate made up of cisplatin, vinblastine, and a penetration enhancer molecule being evaluated for patients with soft tissue sarcoma.

Mechanism-Driven Science Informs Novel Treatments in Soft Tissue Sarcoma
Mechanism-Driven Science Informs Novel Treatments in Soft Tissue Sarcoma

August 11th 2023

Sarcoma Awareness Month: Impact of Molecular Testing and Individualized Treatments
Sarcoma Awareness Month: Impact of Molecular Testing and Individualized Treatments

July 19th 2023

Phase 2 Study of Envafolimab Displays Encouraging ORR in Sarcoma
Phase 2 Study of Envafolimab Displays Encouraging ORR in Sarcoma

June 25th 2023

INT230-6 With/Without Ipilimumab Prolongs Survival in R/R Metastatic Sarcomas
INT230-6 With/Without Ipilimumab Prolongs Survival in R/R Metastatic Sarcomas

June 8th 2023

Video Series
Video Interviews
Podcasts

More News